Valuation: Circio Holding ASA

Market Cap 2.2B 230M 202M 188M 172M 324M 22.13B 329M 2.23B 871M 10.88B 863M 844M 37.62B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 2.2B 230M 202M 188M 172M 324M 22.16B 329M 2.23B 872M 10.89B 864M 845M 37.66B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+3.93%
1 week+19.82%
Current month+25.51%
1 month+21.87%
3 months+7.31%
6 months+740.91%
Current year+694.67%
1 week 7.66
Extreme 7.66
9.4
1 month 7.12
Extreme 7.12
9.4
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap.
11/30/21 Fiscal year

Chief Executive Officer

120,000 0.1386%
5/19/21 Buy

Director

21,299 0.0246%
12/3/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+3.93%+19.82%+1,380.00%-44.14% 230M
+0.93%+6.97%+62.83%+67.97% 57.28B
-1.92%+6.03%+43.68%+84.56% 54.99B
-0.46%-1.29%+3.28%+422.58% 23.18B
-2.97%-2.35%-22.03%-16.54% 22.59B
-0.36%+5.73%+30.99%-3.58% 20.46B
-1.34%+0.51%+25.02%-30.27% 17.56B
-1.44%+5.67%+32.54%+544.11% 15.67B
-1.30%-5.02%+165.62%+291.37% 14.46B
-0.50%-0.98%+23.62%+178.38% 13.92B
Average -0.54%+3.13%+174.56%+149.44% 24.03B
Weighted average by Cap. -0.87%+2.11%+42.46%+135.52%

Financials

2024 2025
Net sales - -
Net income 57.52M 6M 5.27M 4.9M 4.5M 8.46M 578M 8.59M 58.23M 22.75M 284M 22.54M 22.05M 983M -45.91M -4.79M -4.21M -3.91M -3.59M -6.75M -461M -6.85M -46.47M -18.16M -227M -17.99M -17.6M -784M
Net Debt -972K -101K -89.11K -82.87K -76.04K -143K -9.77M -145K -984K -384K -4.8M -381K -373K -16.61M 2.24M 234K 206K 191K 176K 330K 22.57M 335K 2.27M 888K 11.09M 880K 861K 38.36M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
26-07-24 NOK 9.250 +3.93% 6,181,045
26-07-23 NOK 8.900 +1.71% 2,277,238
26-07-22 NOK 8.750 +1.39% 5,491,235
26-07-21 NOK 8.630 +5.12% 7,172,312
26-07-20 NOK 8.210 +6.35% 3,220,159

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock